Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Life Sciences

full industries list
Life Sciences Image
News
Events
Litigation Blog
Hatch-Waxman

Fish attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

Our industry-leading litigation practice regularly represents the world’s largest branded pharmaceutical companies in high-stakes, high-risk litigation. Drug makers trust our litigators to handle their blockbuster Hatch-Waxman, BPCIA, and competitor litigation matters because they possess the unique combination of technical, legal, and industry expertise necessary for success.

Examples of our biotechnology and pharmaceutical work include:

  • Patenting groundbreaking life sciences innovations, including tissue engineering, therapeutic agents and methods, antibodies, and genetically engineered animals
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting IP due diligence on billions of dollars in deal value for pharmaceutical investments, mergers, and acquisitions
  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Litigating ANDA cases on behalf of branded pharmaceuticals
  • Representing biotechnology and pharmaceutical companies in post-grant proceedings at the PTAB, as well as coordinating post-grant and district court litigation strategies

Notable Wins

Fish Wins Federal Circuit Affirmance of Reversal of $200 Million Damages Against Gilead

Fish won a unanimous Federal Circuit opinion today that affirmed its June 2016 post-trial wipe-out of a $200 million jury verdict against client Gilead Sciences, Inc. after proving Merck had forfeited its right to assert its hepatitis C drug patents against Gilead because of litigation and business misconduct constituting “unclean hands.”

Read more about this precedential opinion here and here.

Fish Wipes Out $2.5B Patent Verdict Against Gilead Sciences

Fish & Richardson won a motion for Judgment as a Matter of Law (JMOL) that reversed a $2.5 billion jury verdict against its client Gilead Sciences Inc. in federal court in Delaware.

Read about this historic win here and here.

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
News
September 15, 2021
Annie King, Ph.D., Named IFLR Life Sciences Rising Star
Press Release
News
News
September 3, 2021
Life Sciences Entrepreneur Sourcebook | Intellectual Property: What It Is and Why You Should Care
Articles
News
August 27, 2021
Fish & Richardson Part of Gilead Legal Team That Secures Reversal of $1.2 Billion Judgment Against Kite Pharma for Cancer Therapy
Press Release
News
Event
September 13th, 2021 | 11:55 am EDT
Momentum: The Drug Patent Challenge Strategy Summit - Paragraph IV, Hatch-Waxman
Speaking Engagement
Sponsorship
Event
August 18th, 2021 | 11:30 am EDT
Momentum: Due Diligence for Life Sciences
Speaking Engagement
Sponsorship
News
July 23, 2021
Fish Principal Cindy Walden Authors World IP Review Article, "Brand Owner’s Friend: the Lanham Act at 75"
Articles
News
Event
June 29th, 2021 | 1:00 pm EDT
Pharma Intelligence Webinar | Designing the Deal: Layering the Groundwork for Successful Investment, Partnerships, and Acquisition
Speaking Engagement
Event
June 23rd, 2021 | 2:45 pm EDT
Federal Circuit Bar Association’s 2021 Bench & Bar® Conference
Speaking Engagement
Conference/Convention
Sponsorship
Event
June 24th, 2021 | 1:10 pm EDT
LSX Biotech Startup CEO Forum
Speaking Engagement
Sponsorship
Event
June 23rd, 2021 | 12:00 pm EDT
The Nexus of IP and R&D: Applying Insights to Accelerate Innovation
Speaking Engagement
Webinar
Blog
June 4, 2021
Users of Research Tools Take Note
Author: Brian D. Coggio
Event
June 9th, 2021 | 5:00 am EDT
Pharma Intelligence Webinar | Designing the Deal
Speaking Engagement
Sponsorship
load more topics